Trevi Therapeutics Inc (TRVI)

Stock-Based Compensation

$8.06M

TTM · Period ending: · USD

TRVI logo

TRVI Stock-Based Compensation

Latest reported$8.06M
TRVI TTM Stock-Based Comp ($496.00K → $8.06M)
High-resolution chart · PNG

TRVI stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Trevi Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
8,056,000
6,168,000
5,185,000
4,752,000
4,330,000
4,073,000
3,588,000
3,205,000
2,914,000
2,392,000
2,247,000
2,214,000
2,253,000
2,168,000
2,327,000
2,366,000
2,337,000
2,562,000
2,543,000
2,513,000
2,561,000
2,405,000
2,417,000
2,280,000
2,063,000
1,711,000
1,127,000
939,000
689,000
554,000
496,000
311,060
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.